Thyrocare Technologies, an API Group backed diagnostic laboratory services provider, has announced the appointment of Rahul Guha as its Managing Director and Chief Executive Officer with effect from 16th May 2022.
Guha has joined API Group to head its Diagnostics Business. Guha has spent almost 17 years at Boston Consulting Group (BCG) where he led the Health Care & Life Sciences practice.
Prior to BCG, he was Co-Founder and CEO of Nautilus Software and Chief Technology Officer at ValuePay.com where he was responsible for product development in the US market, according to a statement.
Guha has extensive project experience in MedTech and HealthTech and has worked closely with multiple startups on their digital incubation. He has been an active contributor to the pharma sector and has over two decades of experience, the statement added.
Siddharth Shah, MD and CEO at API Holdings, said, “As we strive towards making healthcare affordable and accessible to every single Indian, we are extremely excited to have Rahul join us in our mission.” Shah further said, “I am elated to share that Rahul will be leading Thyrocare as its MD and CEO and will also be responsible for diagnostics as a segment at the group level. His invaluable experience of over two decades in healthcare will help us scale our diagnostics franchise.”
Rahul Guha, MD and CEO, Thyrocare Technologies, said, “I am very excited to join the phenomenal team at API Group and look forward to delivering a transformative customer experience to diagnostic users which will not only leverage the digital capabilities but also conjoin the extensive network of Thyrocare.”
Guha did his MBA from IIM Bangalore.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.